Stefan A. Dyckerhoff Sells 30,000 Shares of Astera Labs, Inc. (NASDAQ:ALAB) Stock

Astera Labs, Inc. (NASDAQ:ALAB) Director Stefan A. Dyckerhoff sold 30,000 shares of the business’s stock in a transaction dated Friday, November 22nd. The shares were sold at an average price of $105.90, for a total transaction of $3,177,000.00. Following the sale, the director now directly owns 3,765 shares of the company’s stock, valued at approximately $398,713.50. This represents a 88.85 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Astera Labs Trading Down 5.6 %

Astera Labs stock opened at $99.60 on Friday. Astera Labs, Inc. has a 12-month low of $36.22 and a 12-month high of $113.85. The firm has a 50 day simple moving average of $74.17 and a 200-day simple moving average of $60.84.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.06. Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%. The company had revenue of $113.10 million for the quarter, compared to analysts’ expectations of $97.50 million. The firm’s revenue for the quarter was up 47.1% on a year-over-year basis. As a group, equities analysts predict that Astera Labs, Inc. will post -0.45 EPS for the current year.

Analysts Set New Price Targets

ALAB has been the subject of a number of research reports. Stifel Nicolaus lifted their target price on Astera Labs from $80.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft upped their price objective on Astera Labs from $60.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Roth Mkm boosted their price target on shares of Astera Labs from $80.00 to $105.00 and gave the company a “buy” rating in a report on Tuesday, November 5th. Citigroup initiated coverage on shares of Astera Labs in a report on Monday, November 18th. They issued a “buy” rating and a $120.00 price objective on the stock. Finally, Barclays upped their target price on shares of Astera Labs from $70.00 to $87.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. Twelve investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $94.67.

Institutional Investors Weigh In On Astera Labs

Hedge funds and other institutional investors have recently bought and sold shares of the business. Sei Investments Co. bought a new position in shares of Astera Labs during the 1st quarter valued at about $952,000. Vanguard Group Inc. acquired a new stake in Astera Labs during the first quarter valued at approximately $127,268,000. Price T Rowe Associates Inc. MD bought a new stake in Astera Labs during the first quarter worth approximately $44,514,000. Janus Henderson Group PLC bought a new stake in Astera Labs during the first quarter worth approximately $20,025,000. Finally, Rokos Capital Management LLP acquired a new position in Astera Labs in the first quarter worth approximately $1,484,000.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.